Insulin and Beta Cell Targeting

Type2 diabetes mellitus is widely considered a chronic disease without a cure. As beta-cell function progressively declines most of the time, then blood glucose rises. However, recent studies have demonstrated remission of type2 diabetes following bariatric surgery, intensive insulin therapy or very low-calorie diet, raising the possibility that the declining beta-cell function in type2 diabetes may be arrested or even reversed. Future treatment strategies should be revised to target to early beta-cell preservation and those disease remissions.

  • Targeting β-cell mass in type 2 diabetes
  • B-cell science
  • The incretin effect and its mediators
  • Implications for treatment
  • Effects of the incretins on β-cell mass
  • Targeting the pancreatic β-cell to treat diabetes

Related Conference of Insulin and Beta Cell Targeting

February 27-28, 2019

Asia Pacific Diabetes and Endocrinology Congress

Tokyo, Japan

April 17-18, 2019

21st Asia Pacific Diabetes Conference

May 17-18, 2019

2nd Global Experts Meeting on Diabetes, Hypertension & Metabolic Syndrome

Holiday Inn Singapore Atrium | Singapore
May 30-31, 2019

2nd Global Meeting on Diabetes and Endocrinology

Istanbul, Turkey
June 27-28, 2019 |

18th Global Conference on Diabetes & Nursing Care

Amsterdam, Netherlands
July 17-18, 2019

28th European Diabetes Congress

| Edinburgh, Scotland
July 24-25, 2019

29th World Diabetes & Heart Congress

Melbourne, Australia
July 29-30, 2019

12th International Conference on Diabetes & Metabolism

Chicago | Illinois| USA
September 19-20, 2019

15th World Congress on Endocrinology & Diabetes

| Prague, Czech Republic
Oct 03-04, 2019

Euro Diabetes Congress & Expo

| Paris, France
November 25-26, 2019

27th International Diabetes and Healthcare Conference

Istanbul, Turkey

Insulin and Beta Cell Targeting Conference Speakers

Recommended Sessions

Related Journals

Are you interested in